Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40026908
Localisation
New Zealand
Oceania
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
SME
Dernière mise à jour
27/11/2025
Statut
Classification
1.5°C
Année cible
2034
This target was approved using a streamlined target validation route exclusive to small and medium-sized enterprises (SMEs). https://docs.sbtiservices.com/resources/FAQsforSMEs.pdf Canterbury Scientific Limited commits to reduce absolute scope 1 emissions 58.8% by 2034 from a 2024 base year. Canterbury Scientific Limited also commits to maintain zero scope 2 emissions through 2034, and to measure and reduce its scope 3 emissions from a 2024 base year.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques